img

Global Vaginal Anti Infectives Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vaginal Anti Infectives Market Insights, Forecast to 2034

Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. "Yeast" infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
Global Vaginal Anti Infectives market is expected to reach to US$ 3214 million in 2024, with a positive growth of %, compared with US$ 3120 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Vaginal Anti Infectives industry is evaluated to reach US$ 4356.5 million in 2029. The CAGR will be 5.2% during 2024 to 2029.
Globally, Vaginal Anti Infectives key manufacturers include Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company and GSK plc, etc. Pfizer Inc, Mylan N.V, Novartis AG are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Vaginal Anti Infectives were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Vaginal Anti Infectives market and estimated to attract more attentions from industry insiders and investors.
Vaginal Anti Infectives can be divided into Oral and Ointment, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Vaginal Anti Infectives is widely used in various fields, such as Bacterial Vaginitis, Trichomonal Vaginitis and Candida Vaginitis,, etc. Bacterial Vaginitis provides greatest supports to the Vaginal Anti Infectives industry development. In 2022, global % sales of Vaginal Anti Infectives went into Bacterial Vaginitis filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Vaginal Anti Infectives market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Vaginal Anti Infectives market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Bayer
Sanofi
Scynexis
Bausch Health Companies Inc
Segment by Type
Oral
Ointment

Segment by Application


Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Vaginal Anti Infectives plant distribution, commercial date of Vaginal Anti Infectives, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Vaginal Anti Infectives introduction, etc. Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Vaginal Anti Infectives
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Vaginal Anti Infectives Product Introduction
1.2 Market by Type
1.2.1 Global Vaginal Anti Infectives Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Ointment
1.3 Market by Application
1.3.1 Global Vaginal Anti Infectives Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Bacterial Vaginitis
1.3.3 Trichomonal Vaginitis
1.3.4 Candida Vaginitis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vaginal Anti Infectives Sales Estimates and Forecasts 2018-2029
2.2 Global Vaginal Anti Infectives Revenue by Region
2.2.1 Global Vaginal Anti Infectives Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Vaginal Anti Infectives Revenue by Region (2018-2024)
2.2.3 Global Vaginal Anti Infectives Revenue by Region (2024-2029)
2.2.4 Global Vaginal Anti Infectives Revenue Market Share by Region (2018-2029)
2.3 Global Vaginal Anti Infectives Sales Estimates and Forecasts 2018-2029
2.4 Global Vaginal Anti Infectives Sales by Region
2.4.1 Global Vaginal Anti Infectives Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Vaginal Anti Infectives Sales by Region (2018-2024)
2.4.3 Global Vaginal Anti Infectives Sales by Region (2024-2029)
2.4.4 Global Vaginal Anti Infectives Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vaginal Anti Infectives Sales by Manufacturers
3.1.1 Global Vaginal Anti Infectives Sales by Manufacturers (2018-2024)
3.1.2 Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaginal Anti Infectives in 2022
3.2 Global Vaginal Anti Infectives Revenue by Manufacturers
3.2.1 Global Vaginal Anti Infectives Revenue by Manufacturers (2018-2024)
3.2.2 Global Vaginal Anti Infectives Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vaginal Anti Infectives Revenue in 2022
3.3 Global Key Players of Vaginal Anti Infectives, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Vaginal Anti Infectives Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vaginal Anti Infectives, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vaginal Anti Infectives, Product Offered and Application
3.8 Global Key Manufacturers of Vaginal Anti Infectives, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaginal Anti Infectives Sales by Type
4.1.1 Global Vaginal Anti Infectives Historical Sales by Type (2018-2024)
4.1.2 Global Vaginal Anti Infectives Forecasted Sales by Type (2024-2029)
4.1.3 Global Vaginal Anti Infectives Sales Market Share by Type (2018-2029)
4.2 Global Vaginal Anti Infectives Revenue by Type
4.2.1 Global Vaginal Anti Infectives Historical Revenue by Type (2018-2024)
4.2.2 Global Vaginal Anti Infectives Forecasted Revenue by Type (2024-2029)
4.2.3 Global Vaginal Anti Infectives Revenue Market Share by Type (2018-2029)
4.3 Global Vaginal Anti Infectives Price by Type
4.3.1 Global Vaginal Anti Infectives Price by Type (2018-2024)
4.3.2 Global Vaginal Anti Infectives Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Vaginal Anti Infectives Sales by Application
5.1.1 Global Vaginal Anti Infectives Historical Sales by Application (2018-2024)
5.1.2 Global Vaginal Anti Infectives Forecasted Sales by Application (2024-2029)
5.1.3 Global Vaginal Anti Infectives Sales Market Share by Application (2018-2029)
5.2 Global Vaginal Anti Infectives Revenue by Application
5.2.1 Global Vaginal Anti Infectives Historical Revenue by Application (2018-2024)
5.2.2 Global Vaginal Anti Infectives Forecasted Revenue by Application (2024-2029)
5.2.3 Global Vaginal Anti Infectives Revenue Market Share by Application (2018-2029)
5.3 Global Vaginal Anti Infectives Price by Application
5.3.1 Global Vaginal Anti Infectives Price by Application (2018-2024)
5.3.2 Global Vaginal Anti Infectives Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Vaginal Anti Infectives Market Size by Type
6.1.1 US & Canada Vaginal Anti Infectives Sales by Type (2018-2029)
6.1.2 US & Canada Vaginal Anti Infectives Revenue by Type (2018-2029)
6.2 US & Canada Vaginal Anti Infectives Market Size by Application
6.2.1 US & Canada Vaginal Anti Infectives Sales by Application (2018-2029)
6.2.2 US & Canada Vaginal Anti Infectives Revenue by Application (2018-2029)
6.3 US & Canada Vaginal Anti Infectives Market Size by Country
6.3.1 US & Canada Vaginal Anti Infectives Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Vaginal Anti Infectives Sales by Country (2018-2029)
6.3.3 US & Canada Vaginal Anti Infectives Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vaginal Anti Infectives Market Size by Type
7.1.1 Europe Vaginal Anti Infectives Sales by Type (2018-2029)
7.1.2 Europe Vaginal Anti Infectives Revenue by Type (2018-2029)
7.2 Europe Vaginal Anti Infectives Market Size by Application
7.2.1 Europe Vaginal Anti Infectives Sales by Application (2018-2029)
7.2.2 Europe Vaginal Anti Infectives Revenue by Application (2018-2029)
7.3 Europe Vaginal Anti Infectives Market Size by Country
7.3.1 Europe Vaginal Anti Infectives Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Vaginal Anti Infectives Sales by Country (2018-2029)
7.3.3 Europe Vaginal Anti Infectives Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vaginal Anti Infectives Market Size
8.1.1 China Vaginal Anti Infectives Sales (2018-2029)
8.1.2 China Vaginal Anti Infectives Revenue (2018-2029)
8.2 China Vaginal Anti Infectives Market Size by Application
8.2.1 China Vaginal Anti Infectives Sales by Application (2018-2029)
8.2.2 China Vaginal Anti Infectives Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Vaginal Anti Infectives Market Size by Type
9.1.1 Asia Vaginal Anti Infectives Sales by Type (2018-2029)
9.1.2 Asia Vaginal Anti Infectives Revenue by Type (2018-2029)
9.2 Asia Vaginal Anti Infectives Market Size by Application
9.2.1 Asia Vaginal Anti Infectives Sales by Application (2018-2029)
9.2.2 Asia Vaginal Anti Infectives Revenue by Application (2018-2029)
9.3 Asia Vaginal Anti Infectives Sales by Region
9.3.1 Asia Vaginal Anti Infectives Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Vaginal Anti Infectives Revenue by Region (2018-2029)
9.3.3 Asia Vaginal Anti Infectives Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vaginal Anti Infectives Market Size by Type
10.1.1 Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Vaginal Anti Infectives Market Size by Application
10.2.1 Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Country
10.3.1 Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Information
11.1.2 Pfizer Inc Overview
11.1.3 Pfizer Inc Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Inc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Inc Recent Developments
11.2 Mylan N.V
11.2.1 Mylan N.V Company Information
11.2.2 Mylan N.V Overview
11.2.3 Mylan N.V Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Mylan N.V Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan N.V Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis AG Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Hikma Pharmaceuticals plc
11.4.1 Hikma Pharmaceuticals plc Company Information
11.4.2 Hikma Pharmaceuticals plc Overview
11.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hikma Pharmaceuticals plc Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Information
11.5.2 Aurobindo Pharma Overview
11.5.3 Aurobindo Pharma Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Aurobindo Pharma Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aurobindo Pharma Recent Developments
11.6 AbbVie Inc
11.6.1 AbbVie Inc Company Information
11.6.2 AbbVie Inc Overview
11.6.3 AbbVie Inc Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 AbbVie Inc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AbbVie Inc Recent Developments
11.7 Melinta Therapeutics, Inc
11.7.1 Melinta Therapeutics, Inc Company Information
11.7.2 Melinta Therapeutics, Inc Overview
11.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Melinta Therapeutics, Inc Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Information
11.8.2 Bristol-Myers Squibb Company Overview
11.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 GSK plc
11.9.1 GSK plc Company Information
11.9.2 GSK plc Overview
11.9.3 GSK plc Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 GSK plc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GSK plc Recent Developments
11.10 Bayer AG
11.10.1 Bayer AG Company Information
11.10.2 Bayer AG Overview
11.10.3 Bayer AG Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Bayer AG Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer AG Recent Developments
11.11 Lupin
11.11.1 Lupin Company Information
11.11.2 Lupin Overview
11.11.3 Lupin Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Lupin Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lupin Recent Developments
11.12 Perrigo Company plc
11.12.1 Perrigo Company plc Company Information
11.12.2 Perrigo Company plc Overview
11.12.3 Perrigo Company plc Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Perrigo Company plc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Perrigo Company plc Recent Developments
11.13 Bayer
11.13.1 Bayer Company Information
11.13.2 Bayer Overview
11.13.3 Bayer Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Bayer Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Bayer Recent Developments
11.14 Sanofi
11.14.1 Sanofi Company Information
11.14.2 Sanofi Overview
11.14.3 Sanofi Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Sanofi Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sanofi Recent Developments
11.15 Scynexis
11.15.1 Scynexis Company Information
11.15.2 Scynexis Overview
11.15.3 Scynexis Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Scynexis Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Scynexis Recent Developments
11.16 Bausch Health Companies Inc
11.16.1 Bausch Health Companies Inc Company Information
11.16.2 Bausch Health Companies Inc Overview
11.16.3 Bausch Health Companies Inc Vaginal Anti Infectives Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Bausch Health Companies Inc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Bausch Health Companies Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaginal Anti Infectives Industry Chain Analysis
12.2 Vaginal Anti Infectives Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaginal Anti Infectives Production Mode & Process
12.4 Vaginal Anti Infectives Sales and Marketing
12.4.1 Vaginal Anti Infectives Sales Channels
12.4.2 Vaginal Anti Infectives Distributors
12.5 Vaginal Anti Infectives Customers
13 Market Dynamics
13.1 Vaginal Anti Infectives Industry Trends
13.2 Vaginal Anti Infectives Market Drivers
13.3 Vaginal Anti Infectives Market Challenges
13.4 Vaginal Anti Infectives Market Restraints
14 Key Findings in The Global Vaginal Anti Infectives Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaginal Anti Infectives Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Ointment
Table 4. Global Vaginal Anti Infectives Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Vaginal Anti Infectives Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Vaginal Anti Infectives Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Vaginal Anti Infectives Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Vaginal Anti Infectives Revenue Market Share by Region (2018-2024)
Table 9. Global Vaginal Anti Infectives Revenue Market Share by Region (2024-2029)
Table 10. Global Vaginal Anti Infectives Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Vaginal Anti Infectives Sales by Region (2018-2024) & (K Units)
Table 12. Global Vaginal Anti Infectives Sales by Region (2024-2029) & (K Units)
Table 13. Global Vaginal Anti Infectives Sales Market Share by Region (2018-2024)
Table 14. Global Vaginal Anti Infectives Sales Market Share by Region (2024-2029)
Table 15. Global Vaginal Anti Infectives Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Vaginal Anti Infectives Sales Share by Manufacturers (2018-2024)
Table 17. Global Vaginal Anti Infectives Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Vaginal Anti Infectives Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Vaginal Anti Infectives, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Vaginal Anti Infectives Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Vaginal Anti Infectives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vaginal Anti Infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2022)
Table 23. Global Key Manufacturers of Vaginal Anti Infectives, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vaginal Anti Infectives, Product Offered and Application
Table 25. Global Key Manufacturers of Vaginal Anti Infectives, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vaginal Anti Infectives Sales by Type (2018-2024) & (K Units)
Table 28. Global Vaginal Anti Infectives Sales by Type (2024-2029) & (K Units)
Table 29. Global Vaginal Anti Infectives Sales Share by Type (2018-2024)
Table 30. Global Vaginal Anti Infectives Sales Share by Type (2024-2029)
Table 31. Global Vaginal Anti Infectives Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Vaginal Anti Infectives Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Vaginal Anti Infectives Revenue Share by Type (2018-2024)
Table 34. Global Vaginal Anti Infectives Revenue Share by Type (2024-2029)
Table 35. Vaginal Anti Infectives Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Vaginal Anti Infectives Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Vaginal Anti Infectives Sales by Application (2018-2024) & (K Units)
Table 38. Global Vaginal Anti Infectives Sales by Application (2024-2029) & (K Units)
Table 39. Global Vaginal Anti Infectives Sales Share by Application (2018-2024)
Table 40. Global Vaginal Anti Infectives Sales Share by Application (2024-2029)
Table 41. Global Vaginal Anti Infectives Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Vaginal Anti Infectives Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Vaginal Anti Infectives Revenue Share by Application (2018-2024)
Table 44. Global Vaginal Anti Infectives Revenue Share by Application (2024-2029)
Table 45. Vaginal Anti Infectives Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Vaginal Anti Infectives Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Vaginal Anti Infectives Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Vaginal Anti Infectives Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Vaginal Anti Infectives Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Vaginal Anti Infectives Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Vaginal Anti Infectives Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Vaginal Anti Infectives Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Vaginal Anti Infectives Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Vaginal Anti Infectives Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Vaginal Anti Infectives Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Vaginal Anti Infectives Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Vaginal Anti Infectives Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 60. Europe Vaginal Anti Infectives Sales by Type (2018-2024) & (K Units)
Table 61. Europe Vaginal Anti Infectives Sales by Type (2024-2029) & (K Units)
Table 62. Europe Vaginal Anti Infectives Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Vaginal Anti Infectives Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Vaginal Anti Infectives Sales by Application (2018-2024) & (K Units)
Table 65. Europe Vaginal Anti Infectives Sales by Application (2024-2029) & (K Units)
Table 66. Europe Vaginal Anti Infectives Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Vaginal Anti Infectives Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Vaginal Anti Infectives Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Vaginal Anti Infectives Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Vaginal Anti Infectives Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 72. Europe Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 73. China Vaginal Anti Infectives Sales by Type (2018-2024) & (K Units)
Table 74. China Vaginal Anti Infectives Sales by Type (2024-2029) & (K Units)
Table 75. China Vaginal Anti Infectives Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Vaginal Anti Infectives Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Vaginal Anti Infectives Sales by Application (2018-2024) & (K Units)
Table 78. China Vaginal Anti Infectives Sales by Application (2024-2029) & (K Units)
Table 79. China Vaginal Anti Infectives Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Vaginal Anti Infectives Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Vaginal Anti Infectives Sales by Type (2018-2024) & (K Units)
Table 82. Asia Vaginal Anti Infectives Sales by Type (2024-2029) & (K Units)
Table 83. Asia Vaginal Anti Infectives Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Vaginal Anti Infectives Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Vaginal Anti Infectives Sales by Application (2018-2024) & (K Units)
Table 86. Asia Vaginal Anti Infectives Sales by Application (2024-2029) & (K Units)
Table 87. Asia Vaginal Anti Infectives Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Vaginal Anti Infectives Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Vaginal Anti Infectives Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Vaginal Anti Infectives Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Vaginal Anti Infectives Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Vaginal Anti Infectives Sales by Region (2018-2024) & (K Units)
Table 93. Asia Vaginal Anti Infectives Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 107. Pfizer Inc Company Information
Table 108. Pfizer Inc Description and Major Businesses
Table 109. Pfizer Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Inc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Inc Recent Developments
Table 112. Mylan N.V Company Information
Table 113. Mylan N.V Description and Major Businesses
Table 114. Mylan N.V Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Mylan N.V Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Mylan N.V Recent Developments
Table 117. Novartis AG Company Information
Table 118. Novartis AG Description and Major Businesses
Table 119. Novartis AG Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Novartis AG Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Novartis AG Recent Developments
Table 122. Hikma Pharmaceuticals plc Company Information
Table 123. Hikma Pharmaceuticals plc Description and Major Businesses
Table 124. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Hikma Pharmaceuticals plc Recent Developments
Table 127. Aurobindo Pharma Company Information
Table 128. Aurobindo Pharma Description and Major Businesses
Table 129. Aurobindo Pharma Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Aurobindo Pharma Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Aurobindo Pharma Recent Developments
Table 132. AbbVie Inc Company Information
Table 133. AbbVie Inc Description and Major Businesses
Table 134. AbbVie Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. AbbVie Inc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. AbbVie Inc Recent Developments
Table 137. Melinta Therapeutics, Inc Company Information
Table 138. Melinta Therapeutics, Inc Description and Major Businesses
Table 139. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Melinta Therapeutics, Inc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Melinta Therapeutics, Inc Recent Developments
Table 142. Bristol-Myers Squibb Company Company Information
Table 143. Bristol-Myers Squibb Company Description and Major Businesses
Table 144. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Bristol-Myers Squibb Company Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bristol-Myers Squibb Company Recent Developments
Table 147. GSK plc Company Information
Table 148. GSK plc Description and Major Businesses
Table 149. GSK plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. GSK plc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. GSK plc Recent Developments
Table 152. Bayer AG Company Information
Table 153. Bayer AG Description and Major Businesses
Table 154. Bayer AG Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Bayer AG Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Bayer AG Recent Developments
Table 157. Lupin Company Information
Table 158. Lupin Description and Major Businesses
Table 159. Lupin Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Lupin Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Lupin Recent Developments
Table 162. Perrigo Company plc Company Information
Table 163. Perrigo Company plc Description and Major Businesses
Table 164. Perrigo Company plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Perrigo Company plc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Perrigo Company plc Recent Developments
Table 167. Bayer Company Information
Table 168. Bayer Description and Major Businesses
Table 169. Bayer Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Bayer Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Bayer Recent Developments
Table 172. Sanofi Company Information
Table 173. Sanofi Description and Major Businesses
Table 174. Sanofi Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Sanofi Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Sanofi Recent Developments
Table 177. Scynexis Company Information
Table 178. Scynexis Description and Major Businesses
Table 179. Scynexis Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Scynexis Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Scynexis Recent Developments
Table 182. Bausch Health Companies Inc Company Information
Table 183. Bausch Health Companies Inc Description and Major Businesses
Table 184. Bausch Health Companies Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Bausch Health Companies Inc Vaginal Anti Infectives Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Bausch Health Companies Inc Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Vaginal Anti Infectives Distributors List
Table 190. Vaginal Anti Infectives Customers List
Table 191. Vaginal Anti Infectives Market Trends
Table 192. Vaginal Anti Infectives Market Drivers
Table 193. Vaginal Anti Infectives Market Challenges
Table 194. Vaginal Anti Infectives Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaginal Anti Infectives Product Picture
Figure 2. Global Vaginal Anti Infectives Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vaginal Anti Infectives Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Ointment Product Picture
Figure 6. Global Vaginal Anti Infectives Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Vaginal Anti Infectives Market Share by Application in 2022 & 2029
Figure 8. Bacterial Vaginitis
Figure 9. Trichomonal Vaginitis
Figure 10. Candida Vaginitis
Figure 11. Vaginal Anti Infectives Report Years Considered
Figure 12. Global Vaginal Anti Infectives Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Vaginal Anti Infectives Revenue 2018-2029 (US$ Million)
Figure 14. Global Vaginal Anti Infectives Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Vaginal Anti Infectives Revenue Market Share by Region (2018-2029)
Figure 16. Global Vaginal Anti Infectives Sales 2018-2029 ((K Units)
Figure 17. Global Vaginal Anti Infectives Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Vaginal Anti Infectives Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Vaginal Anti Infectives Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Vaginal Anti Infectives Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Vaginal Anti Infectives Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Vaginal Anti Infectives Sales YoY (2018-2029) & (K Units)
Figure 23. China Vaginal Anti Infectives Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Vaginal Anti Infectives Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Vaginal Anti Infectives Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Vaginal Anti Infectives Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Vaginal Anti Infectives Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Vaginal Anti Infectives in the World: Market Share by Vaginal Anti Infectives Revenue in 2022
Figure 30. Global Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Vaginal Anti Infectives Sales Market Share by Type (2018-2029)
Figure 32. Global Vaginal Anti Infectives Revenue Market Share by Type (2018-2029)
Figure 33. Global Vaginal Anti Infectives Sales Market Share by Application (2018-2029)
Figure 34. Global Vaginal Anti Infectives Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Vaginal Anti Infectives Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Vaginal Anti Infectives Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Vaginal Anti Infectives Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Vaginal Anti Infectives Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Vaginal Anti Infectives Revenue Share by Country (2018-2029)
Figure 40. US & Canada Vaginal Anti Infectives Sales Share by Country (2018-2029)
Figure 41. U.S. Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Vaginal Anti Infectives Sales Market Share by Type (2018-2029)
Figure 44. Europe Vaginal Anti Infectives Revenue Market Share by Type (2018-2029)
Figure 45. Europe Vaginal Anti Infectives Sales Market Share by Application (2018-2029)
Figure 46. Europe Vaginal Anti Infectives Revenue Market Share by Application (2018-2029)
Figure 47. Europe Vaginal Anti Infectives Revenue Share by Country (2018-2029)
Figure 48. Europe Vaginal Anti Infectives Sales Share by Country (2018-2029)
Figure 49. Germany Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 50. France Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 54. China Vaginal Anti Infectives Sales Market Share by Type (2018-2029)
Figure 55. China Vaginal Anti Infectives Revenue Market Share by Type (2018-2029)
Figure 56. China Vaginal Anti Infectives Sales Market Share by Application (2018-2029)
Figure 57. China Vaginal Anti Infectives Revenue Market Share by Application (2018-2029)
Figure 58. Asia Vaginal Anti Infectives Sales Market Share by Type (2018-2029)
Figure 59. Asia Vaginal Anti Infectives Revenue Market Share by Type (2018-2029)
Figure 60. Asia Vaginal Anti Infectives Sales Market Share by Application (2018-2029)
Figure 61. Asia Vaginal Anti Infectives Revenue Market Share by Application (2018-2029)
Figure 62. Asia Vaginal Anti Infectives Revenue Share by Region (2018-2029)
Figure 63. Asia Vaginal Anti Infectives Sales Share by Region (2018-2029)
Figure 64. Japan Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 68. India Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Vaginal Anti Infectives Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Vaginal Anti Infectives Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Vaginal Anti Infectives Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Vaginal Anti Infectives Sales Share by Country (2018-2029)
Figure 75. Brazil Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Vaginal Anti Infectives Revenue (2018-2029) & (US$ Million)
Figure 80. Vaginal Anti Infectives Value Chain
Figure 81. Vaginal Anti Infectives Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries